Active ingredientSarpogrelateCat. No. P-S019-001CAS 125926-17-2Family · Pharmaceutical analytical standards
Sarpogrelate
A serotonin 5-HT2A receptor antagonist that curbs serotonin-induced platelet aggregation; it is used for peripheral artery disease and other chronic arterial occlusions. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?It barely crosses the blood-brain barrier, which is why it is called peripherally selective: it acts on blood vessels and platelets without reaching the brain to any significant extent.
Go to the active ingredient →Active ingredientSarpogrelateCat. No. P-S019-001CAS 125926-17-2
Active ingredientSarpogrelate HClCat. No. P-S019-002CAS 135159-51-2
MetaboliteSarpogrelate Metabolite 1 HydrochlorideCat. No. P-S019-003CAS 135261-74-4
Isotopically labelledSarpogrelate-d3 HClCat. No. P-S019-004CAS 2934185-00-7
Impurity1-(Benzyloxy)-2-(3-methoxystyryl)benzeneCat. No. P-S019-005CAS 1072930-86-9
ImpuritySarpogrelate Impurity 1Cat. No. P-S019-006CAS 1140968-46-2
ImpuritySarpogrelate Impurity 2Cat. No. P-S019-007CAS 138656-64-1
ImpuritySarpogrelate Related Compound I HClCat. No. P-S019-008
ImpuritySarpogrelate Related Compound IICat. No. P-S019-009CAS 1659311-44-0
ImpuritySarpogrelate Impurity 3 HydrochlorideCat. No. P-S019-010
ImpuritySarpogrelate Related Compound IVCat. No. P-S019-011No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.